BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24385809)

  • 1. Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.
    Karakaya P; Yılmaz S; Tüfekçi O; Kır M; Böber E; Irken G; Oren H
    Turk J Haematol; 2013 Sep; 30(3):290-9. PubMed ID: 24385809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late effects in survivors of infant leukemia.
    Leung W; Hudson M; Zhu Y; Rivera GK; Ribeiro RC; Sandlund JT; Bowman LC; Evans WE; Kun L; Pui CH
    Leukemia; 2000 Jul; 14(7):1185-90. PubMed ID: 10914540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Markers of metabolic syndrome and peptides regulating metabolism in survivors of childhood acute lymphoblastic leukemia].
    Skoczeń S; Tomasik P; Balwierz W; Surmiak M; Sztefko K; Galicka-Latała D
    Przegl Lek; 2011; 68(9):592-6. PubMed ID: 22335007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Frequency of Metabolic Syndrome and Serum Osteopontin Levels in Survivors of Childhood Acute Lymphoblastic Leukemia.
    Özdemir ZC; Düzenli Kar Y; Demiral M; Sırmagül B; Bör Ö; Kırel B
    J Adolesc Young Adult Oncol; 2018 Aug; 7(4):480-487. PubMed ID: 29641359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study.
    Williams HE; Howell CR; Chemaitilly W; Wilson CL; Karol SE; Nolan VG; Smeltzer MP; Green DM; Ehrhardt MJ; Mulrooney DA; Pui CH; Hudson MM; Robison LL; Ness KK
    Cancer; 2020 Feb; 126(4):870-878. PubMed ID: 31714590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia.
    Oeffinger KC; Buchanan GR; Eshelman DA; Denke MA; Andrews TC; Germak JA; Tomlinson GE; Snell LE; Foster BM
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):424-30. PubMed ID: 11878576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index predicts insulin resistance in survivors of pediatric acute lymphoblastic leukemia.
    Lowas S; Malempati S; Marks D
    Pediatr Blood Cancer; 2009 Jul; 53(1):58-63. PubMed ID: 19340854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group.
    Pakakasama S; Veerakul G; Sosothikul D; Chainansamit SO; Laosombat V; Thanarattanakorn P; Lumkul R; Wiangnon S; Wangruangsathit S; Narkbunnam N; Kanjanapongkul S
    Int J Hematol; 2010 Jun; 91(5):850-4. PubMed ID: 20490729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects in long-term survivors after treatment for childhood acute leukemia.
    Haddy TB; Mosher RB; Reaman GH
    Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia.
    Elitzur S; Houri-Shtrecher R; Yackobovitz-Gavan M; Avrahami G; Barzilai S; Gilad G; Lebenthal Y; Phillip M; Stark B; Yaniv I; Shalitin S
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):869-877. PubMed ID: 28742520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Obesity and Hepatic Late Adverse Effects in the Egyptian Survivors of Pediatric Acute Lymphoblastic Leukemia: a Single Center Study.
    El-Rashedy FH; El-Hawy MA; El Hefnawy SM; Mohammed MM
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017026. PubMed ID: 28512555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity in long-term survivors of childhood acute lymphoblastic leukemia.
    Asner S; Ammann RA; Ozsahin H; Beck-Popovic M; von der Weid NX
    Pediatr Blood Cancer; 2008 Jul; 51(1):118-22. PubMed ID: 18338394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
    Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
    Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment.
    Brown AL; Lupo PJ; Danysh HE; Okcu MF; Scheurer ME; Kamdar KY
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):429-36. PubMed ID: 26989911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Endocrine Late Complications in Childhood Acute Lymphoblastic Leukemia Survivors: A Report of a Single-Center Experience and Review of the Literature.
    Bayram C; Yaralı N; Fettah A; Demirel F; Tavil B; Kara A; Tunç B
    Turk J Haematol; 2017 Mar; 34(1):40-45. PubMed ID: 27094350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
    Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
    Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.
    Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I
    J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of obesity and metabolic syndrome in childhood leukemia and lymphoma survivors.
    Kartal İ; Alaçam A; Dağdemir A; Kara C; Dinçer OS; Albayrak C; Elli M
    Diabetol Metab Syndr; 2022 Jan; 14(1):16. PubMed ID: 35073984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.